The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it strong buy, with a mean price target of $22.
Sands China Ltd.
1928.HK · UNKNOWN · USD
Sands China Ltd.
FAIL · Does not pass the screenScreen close, 2026-09-18 · not a live quote
Last reviewed 18 days ago
Screened 2026-09-18 · the tape above runs as of 17:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 12.24 against the desk's fair-value range, base estimate 21.70, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Sands China Ltd. holds its Markdown at $12.24. The statistical read favours the sellers, held for 4 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 4 days |
| Price at the screen | $12.24 |
| Valuation | 14.57 trailing · 10.71 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.50 |
Five Screens, Shown in Full
Does not pass. Business activity: gambling
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Sands China does not clear the screen at the business-activity stage. It operates in gambling, so the financial ratios are not the deciding factor here.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. A 77.3% margin of safety to the base estimate.
Third-party analyst targets: 18 covering, consensus Strong Buy. The average target sits +49% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 10.7xfairly priced for its growth rate |
| Trailing P/E | 14.6xreasonably valued |
| EPS, trailing | 0.84 |
| EPS, forward | 1.14 |
| Revenue growth | +11.1%steady growth |
| Profit margin | 11.3%thin but positive margins |
| Return on equity | 73.2%an exceptional return on shareholder capital |
| Debt to equity | 5.00heavy leverage: higher risk if revenue softens |
| Current ratio | 0.61below 1: short-term bills exceed liquid assets |
| Beta | 0.50barely tracks the market's swings |
| 52-week range | 12.77 - 22.50 |
| Moat | STRONG |
The risks · The things to watch: its business and earnings are exposed to Macau and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade1928.HK trades on UNKNOWN (the company is based in Macau). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it strong buy, with a mean price target of $22.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it strong buy, with a mean price target of $22.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it strong buy, with a mean price target of $22.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (20 analysts) rates it strong buy, with a mean price target of $22.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Las Vegas Sands Bets on Premium Travel Through a Massive Upgrade Cycle Zacks · 24 Jul 2026
- Las Vegas Sands Q2 Earnings Call Highlights MarketBeat · 22 Jul 2026
- Sands China (SEHK:1928) Stock Valuation Check As P/E Premium Contrasts With DCF Upside Simply Wall St. · 12 Jun 2026
- Assessing Sands China (SEHK:1928) Valuation As P/E Premium Contrasts With Discounted Cash Flow Signal Simply Wall St. · 13 May 2026
- How Shifting Institutional Stakes and Macao Cultural Push Could Shape Las Vegas Sands' (LVS) Story Simply Wall St. · 16 Mar 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.57 | -4.4% | $0.50 | $989 | -1.1% |
| 2 months | $16.66 | -10.6% | $0.50 | $924 | -7.6% |
| 3 months | $16.68 | -10.8% | $0.50 | $922 | -7.8% |
| 6 months | $20.06 | -25.8% | $0.50 | $767 | -23.3% |
| 1 year | $15.19 | -2.0% | $0.75 | $1,030 | +3.0% |
| 2 years | $17.48 | -14.8% | $1.00 | $909 | -9.1% |
| 3 years | $25.69 | -42.0% | $1.00 | $619 | -38.1% |
| 5 years | $31.94 | -53.4% | $1.00 | $497 | -50.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 1928.HK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.